|  | | VQR |  | Name: | methyl (4~{S})-4-[[(2~{S})-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]pentanoate |  | Formula: | C24 H35 N3 O6 |  | SMILES: | COC(=O)CC[CH](C[CH]1CCNC1=O)NC(=O)[CH](CC(C)C)NC(=O)OCc2ccccc2 |  | InChi: | InChI=1S/C24H35N3O6/c1-16(2)13-20(27-24(31)33-15-17-7-5-4-6-8-17)23(30)26-19(9-10-21(28)32-3)14-18-11-12-25-22(18)29/h4-8,16,18-20H,9-15H2,1-3H3,(H,25,29)(H,26,30)(H,27,31)/t18-,19-,20-/m0/s1 |  | Definition date: | 2023-03-28 |  | Last modified: | 2024-09-27 |  | Release date: | 2024-01-17 |  | Identifier: | methyl (4~{S})-4-[[(2~{S})-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]pentanoate | 
 | 
|  | | SXD |  | Name: | N-{2-[(3,5-dioxohexyl)sulfanyl]ethyl}-N~3~-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alaninamide |  | Formula: | C17 H31 N2 O9 P S |  | SMILES: | O=C(NCCSCCC(=O)CC(=O)C)CCNC(=O)C(O)C(C)(C)COP(=O)(O)O |  | InChi: | InChI=1S/C17H31N2O9PS/c1-12(20)10-13(21)5-8-30-9-7-18-14(22)4-6-19-16(24)15(23)17(2,3)11-28-29(25,26)27/h15,23H,4-11H2,1-3H3,(H,18,22)(H,19,24)(H2,25,26,27)/t15-/m1/s1 |  | Definition date: | 2009-04-02 |  | Last modified: | 2024-09-27 |  | Identifier: | N-{2-[(3,5-dioxohexyl)sulfanyl]ethyl}-N~3~-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alaninamide | 
 | 
|  | | WLP |  | Name: | 2-chlorobenzene-1-thiol |  | Formula: | C6 H5 Cl S |  | SMILES: | c1cccc(c1Cl)S |  | InChi: | InChI=1S/C6H5ClS/c7-5-3-1-2-4-6(5)8/h1-4,8H |  | Definition date: | 2020-10-30 |  | Last modified: | 2024-09-27 |  | Release date: | 2020-11-11 |  | Identifier: | 2-chlorobenzene-1-thiol | 
 | 
|  | | RPI |  | Name: | phospho-arginine |  | Formula: | C6 H15 N4 O5 P |  | SMILES: | N[CH](CCCNC(=N)N[P](O)(O)=O)C(O)=O |  | InChi: | InChI=1S/C6H15N4O5P/c7-4(5(11)12)2-1-3-9-6(8)10-16(13,14)15/h4H,1-3,7H2,(H,11,12)(H5,8,9,10,13,14,15)/t4-/m0/s1 |  | Definition date: | 2016-01-02 |  | Last modified: | 2024-09-27 |  | Release date: | 2016-10-12 |  | Identifier: | (2~{S})-2-azanyl-5-[(~{N}-phosphonocarbamimidoyl)amino]pentanoic acid | 
 | 
|  | | UWO |  | Name: | methyl (6~{R})-5-ethanoyl-7-oxidanylidene-6-[4-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-6~{H}-benzo[b][1,4]benzodiazepine-2-carboxylate |  | Formula: | C24 H21 F3 N2 O4 |  | SMILES: | COC(=O)c1ccc2N([CH](c3ccc(cc3)C(F)(F)F)C4=C(CCCC4=O)Nc2c1)C(C)=O |  | InChi: | InChI=1S/C24H21F3N2O4/c1-13(30)29-19-11-8-15(23(32)33-2)12-18(19)28-17-4-3-5-20(31)21(17)22(29)14-6-9-16(10-7-14)24(25,26)27/h6-12,22,28H,3-5H2,1-2H3/t22-/m1/s1 |  | Definition date: | 2023-06-23 |  | Last modified: | 2024-09-27 |  | Release date: | 2023-08-16 |  | Identifier: | methyl (6~{R})-5-ethanoyl-7-oxidanylidene-6-[4-(trifluoromethyl)phenyl]-8,9,10,11-tetrahydro-6~{H}-benzo[b][1,4]benzodiazepine-2-carboxylate | 
 | 
|  | | SXE |  | Name: | O-{(S)-ETHOXY[(1-METHYLETHYL)AMINO]PHOSPHORYL}-L-SERINE |  | Formula: | C8 H19 N2 O5 P |  | SMILES: | O=P(OCC)(OCC(N)C(=O)O)NC(C)C |  | InChi: | InChI=1S/C8H19N2O5P/c1-4-14-16(13,10-6(2)3)15-5-7(9)8(11)12/h6-7H,4-5,9H2,1-3H3,(H,10,13)(H,11,12)/t7-,16-/m0/s1 |  | Definition date: | 2007-02-13 |  | Last modified: | 2024-09-27 |  | Identifier: | O-{(S)-ethoxy[(1-methylethyl)amino]phosphoryl}-L-serine | 
 | 
|  | | O1R |  | Name: | (2M)-6-chloro-2-(5H-pyrrolo[3,2-d]pyrimidin-5-yl)pyridine-3-carbonitrile |  | Formula: | C12 H6 Cl N5 |  | SMILES: | N#Cc1ccc(Cl)nc1n1ccc2ncncc21 |  | InChi: | InChI=1S/C12H6ClN5/c13-11-2-1-8(5-14)12(17-11)18-4-3-9-10(18)6-15-7-16-9/h1-4,6-7H |  | Definition date: | 2022-04-15 |  | Last modified: | 2024-09-27 |  | Release date: | 2022-07-06 |  | Identifier: | (2M)-6-chloro-2-(5H-pyrrolo[3,2-d]pyrimidin-5-yl)pyridine-3-carbonitrile | 
 | 
|  | | QX7 |  | Name: | N-acetyl-3-{[5-(fluorosulfonyl)-2-methylbenzene-1-carbonyl]amino}-L-alanine |  | Formula: | C13 H15 F N2 O6 S |  | SMILES: | c1c(c(ccc1S(=O)(=O)F)C)C(NCC(C(=O)O)NC(=O)C)=O |  | InChi: | InChI=1S/C13H15FN2O6S/c1-7-3-4-9(23(14,21)22)5-10(7)12(18)15-6-11(13(19)20)16-8(2)17/h3-5,11H,6H2,1-2H3,(H,15,18)(H,16,17)(H,19,20)/t11-/m0/s1 |  | Definition date: | 2020-01-10 |  | Last modified: | 2024-09-27 |  | Release date: | 2020-12-30 |  | Identifier: | N-acetyl-3-{[5-(fluorosulfonyl)-2-methylbenzene-1-carbonyl]amino}-L-alanine | 
 | 
|  | | XTJ |  | Name: | (3-fluorophenyl)methyl [(2S)-3-cyclopropyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]carbamate |  | Formula: | C21 H28 F N3 O5 |  | SMILES: | C3(=O)C(CC(CO)NC(C(CC1CC1)NC(=O)OCc2cccc(c2)F)=O)CCN3 |  | InChi: | InChI=1S/C21H28FN3O5/c22-16-3-1-2-14(8-16)12-30-21(29)25-18(9-13-4-5-13)20(28)24-17(11-26)10-15-6-7-23-19(15)27/h1-3,8,13,15,17-18,26H,4-7,9-12H2,(H,23,27)(H,24,28)(H,25,29)/t15-,17-,18-/m0/s1 |  | Definition date: | 2021-01-12 |  | Last modified: | 2024-09-27 |  | Release date: | 2021-07-07 |  | Identifier: | (3-fluorophenyl)methyl [(2S)-3-cyclopropyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate | 
 | 
|  | | YKA |  | Name: | (1R,2S)-2-((S)-2-((((2-(4,4-difluorocyclohexyl)propan-2-yl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl)propane-1-sulfonic acid |  | Formula: | C23 H37 F2 N3 O8 S |  | SMILES: | O=C1N=CCC1CC(NC(=O)C(CC(C)C)NC(=O)OC(C)(C)C1CCC(F)(F)CC1)C(O)S(=O)(=O)O |  | InChi: | InChI=1S/C23H37F2N3O8S/c1-13(2)11-16(28-21(32)36-22(3,4)15-5-8-23(24,25)9-6-15)19(30)27-17(20(31)37(33,34)35)12-14-7-10-26-18(14)29/h10,13-17,20,31H,5-9,11-12H2,1-4H3,(H,27,30)(H,28,32)(H,33,34,35)/t14-,16-,17-,20+/m0/s1 |  | Definition date: | 2021-03-11 |  | Last modified: | 2024-09-27 |  | Release date: | 2021-03-24 |  | Identifier: | (1R,2S)-2-{[N-({[2-(4,4-difluorocyclohexyl)propan-2-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propane-1-sulfonic acid | 
 | 
|  | | UWQ |  | Name: | 4-(4-methoxypiperidin-1-yl)sulfonylbenzaldehyde |  | Formula: | C13 H17 N O4 S |  | SMILES: | COC1CCN(CC1)[S](=O)(=O)c2ccc(C=O)cc2 |  | InChi: | InChI=1S/C13H17NO4S/c1-18-12-6-8-14(9-7-12)19(16,17)13-4-2-11(10-15)3-5-13/h2-5,10,12H,6-9H2,1H3 |  | Definition date: | 2021-03-24 |  | Last modified: | 2024-09-27 |  | Release date: | 2021-06-09 |  | Identifier: | 4-(4-methoxypiperidin-1-yl)sulfonylbenzaldehyde | 
 | 
|  | | LMB |  | Name: | Leptomycin B, bound form |  | Formula: | C33 H52 O7 |  | SMILES: | O=C(O)CCC(C)C(O)/C=C/C(=CC(C)C/C=C/C(=C/C(C(=O)C(C)C(O)C(C)CC(=CC(=O)O)C)C)C)CC |  | InChi: | InChI=1S/C33H52O7/c1-9-28(14-15-29(34)24(5)13-16-30(35)36)19-22(3)12-10-11-21(2)17-25(6)32(39)27(8)33(40)26(7)18-23(4)20-31(37)38/h10-11,14-15,17,19-20,22,24-27,29,33-34,40H,9,12-13,16,18H2,1-8H3,(H,35,36)(H,37,38)/b11-10+,15-14+,21-17+,23-20+,28-19-/t22-,24+,25-,26+,27-,29+,33-/m1/s1 |  | Definition date: | 2012-10-11 |  | Last modified: | 2024-09-27 |  | Release date: | 2013-01-04 |  | Identifier: | (2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E,20R,21S)-17-ethyl-6,20-dihydroxy-3,5,7,9,11,15,21-heptamethyl-8-oxotetracosa-2,10,12,16,18-pentaenedioic acid | 
 | 
|  | | ZM5 |  | Name: | (2R)-2-(tridecanoyloxy)propyl hexadecanoate |  | Formula: | C32 H62 O5 |  | SMILES: | CCCCCCCCCCCCCCCC(=O)OC[CH](CO)OC(=O)CCCCCCCCCCCC |  | InChi: | InChI=1S/C32H62O5/c1-3-5-7-9-11-13-15-16-17-19-20-22-24-26-31(34)36-29-30(28-33)37-32(35)27-25-23-21-18-14-12-10-8-6-4-2/h30,33H,3-29H2,1-2H3/t30-/m1/s1 |  | Synonyms: | (3-oxidanyl-2-tridecanoyloxy-propyl) hexadecanoate |  | Definition date: | 2024-01-22 |  | Last modified: | 2024-09-27 |  | Release date: | 2024-04-17 |  | Identifier: | (3-oxidanyl-2-tridecanoyloxy-propyl) hexadecanoate | 
 | 
|  | | YYA |  | Name: | 2,4,5-trideoxy-2-(methylamino)-4-[(2Z)-penta-2,4-dien-1-yl]-L-xylonic acid |  | Formula: | C11 H19 N O3 |  | SMILES: | O=C(O)C(NC)C(O)C(CC=C/C=C)C |  | InChi: | InChI=1S/C11H19NO3/c1-4-5-6-7-8(2)10(13)9(12-3)11(14)15/h4-6,8-10,12-13H,1,7H2,2-3H3,(H,14,15)/b6-5-/t8-,9+,10-/m1/s1 |  | Definition date: | 2010-11-19 |  | Last modified: | 2024-09-27 |  | Identifier: | 2,4,5-trideoxy-2-(methylamino)-4-[(2Z)-penta-2,4-dien-1-yl]-L-xylonic acid | 
 | 
|  | | N8U |  | Name: | ~{N}-(1~{H}-indazol-5-yl)ethanesulfonamide |  | Formula: | C9 H11 N3 O2 S |  | SMILES: | CC[S](=O)(=O)Nc1ccc2[nH]ncc2c1 |  | InChi: | InChI=1S/C9H11N3O2S/c1-2-15(13,14)12-8-3-4-9-7(5-8)6-10-11-9/h3-6,12H,2H2,1H3,(H,10,11) |  | Definition date: | 2022-08-12 |  | Last modified: | 2024-09-27 |  | Release date: | 2022-09-28 |  | Identifier: | ~{N}-(1~{H}-indazol-5-yl)ethanesulfonamide | 
 | 
|  | | MFC |  | Name: | 5-[1-(3-FLUORO-4-HYDROXY-PHENYL)-METH-(Z)-YLIDENE]-3,5-DIHYDRO-IMIDAZOL-4-ONE |  | Formula: | C15 H16 F N3 O5 |  | SMILES: | Fc1c(O)ccc(c1)C=C2/N=C(N(C2=O)CC(=O)O)C(N)C(O)C |  | InChi: | InChI=1S/C15H16FN3O5/c1-7(20)13(17)14-18-10(15(24)19(14)6-12(22)23)5-8-2-3-11(21)9(16)4-8/h2-5,7,13,20-21H,6,17H2,1H3,(H,22,23)/b10-5-/t7-,13+/m1/s1 |  | Definition date: | 2004-01-05 |  | Last modified: | 2024-09-27 |  | Identifier: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3-fluoro-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | 
 | 
|  | | WLU |  | Name: | (4R)-5-hydroxy-N-methyl-L-leucine |  | Formula: | C7 H15 N O3 |  | SMILES: | O=C(O)C(NC)CC(C)CO |  | InChi: | InChI=1S/C7H15NO3/c1-5(4-9)3-6(8-2)7(10)11/h5-6,8-9H,3-4H2,1-2H3,(H,10,11)/t5-,6+/m1/s1 |  | Definition date: | 2013-06-18 |  | Last modified: | 2024-09-27 |  | Release date: | 2013-09-18 |  | Identifier: | (4R)-5-hydroxy-N-methyl-L-leucine | 
 | 
|  | | SXH |  | Name: | S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate |  | Formula: | C17 H33 N2 O8 P S |  | SMILES: | O=C(SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)O)CCCCC |  | InChi: | InChI=1S/C17H33N2O8PS/c1-4-5-6-7-14(21)29-11-10-18-13(20)8-9-19-16(23)15(22)17(2,3)12-27-28(24,25)26/h15,22H,4-12H2,1-3H3,(H,18,20)(H,19,23)(H2,24,25,26)/t15-/m1/s1 |  | Definition date: | 2009-04-01 |  | Last modified: | 2024-09-27 |  | Identifier: | S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate | 
 | 
|  | | LMC |  | Name: | (2E,4E,6E)-3-methyl-6-(1,3,3-trimethyl-1,3-dihydro-2H-indol-2-ylidene)hexa-2,4-dienal |  | Formula: | C18 H21 N O |  | SMILES: | O=CC=C(C=CC=C2N(c1ccccc1C2(C)C)C)C |  | InChi: | InChI=1S/C18H21NO/c1-14(12-13-20)8-7-11-17-18(2,3)15-9-5-6-10-16(15)19(17)4/h5-13H,1-4H3/b8-7+,14-12+,17-11+ |  | Synonyms: | (2E,4E,6Z)-3-methyl-6-(1,3,3-trimethylindolin-2-ylidene)hexa-2,4-dienal |  | Definition date: | 2008-12-09 |  | Last modified: | 2024-09-27 |  | Identifier: | (2E,4E,6E)-3-methyl-6-(1,3,3-trimethyl-1,3-dihydro-2H-indol-2-ylidene)hexa-2,4-dienal | 
 | 
|  | | N8W |  | Name: | ~{N}-[(6~{S},7~{R},8~{S},8~{a}~{R})-7,8-bis(oxidanyl)-3-oxidanylidene-1,5,6,7,8,8~{a}-hexahydro-[1,3]oxazolo[3,4-a]pyridin-6-yl]ethanamide |  | Formula: | C9 H14 N2 O5 |  | SMILES: | CC(=O)N[CH]1CN2[CH](COC2=O)[CH](O)[CH]1O |  | InChi: | InChI=1S/C9H14N2O5/c1-4(12)10-5-2-11-6(3-16-9(11)15)8(14)7(5)13/h5-8,13-14H,2-3H2,1H3,(H,10,12)/t5-,6+,7+,8-/m0/s1 |  | Definition date: | 2019-11-15 |  | Last modified: | 2024-09-27 |  | Release date: | 2020-04-08 |  | Identifier: | ~{N}-[(6~{S},7~{R},8~{S},8~{a}~{R})-7,8-bis(oxidanyl)-3-oxidanylidene-1,5,6,7,8,8~{a}-hexahydro-[1,3]oxazolo[3,4-a]pyridin-6-yl]ethanamide | 
 | 
|  | | MFD |  | Name: | (2S,3S,8S,9S)-3-AMINO-9-METHOXY-2,6,8-TRIMETHYL-10-PHENYLDECA-4,6-DIENOIC ACID |  | Formula: | C20 H29 N O3 |  | SMILES: | O=C(O)C(C)C(N)/C=C/C(=C/C(C(OC)Cc1ccccc1)C)C |  | InChi: | InChI=1S/C20H29NO3/c1-14(10-11-18(21)16(3)20(22)23)12-15(2)19(24-4)13-17-8-6-5-7-9-17/h5-12,15-16,18-19H,13,21H2,1-4H3,(H,22,23)/b11-10+,14-12+/t15-,16+,18+,19-/m1/s1 |  | Definition date: | 1999-08-05 |  | Last modified: | 2024-09-27 |  | Identifier: | (2S,3S,4E,6E,8R,9R)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid | 
 | 
|  | | XTM |  | Name: | N~2~-{[(3-fluorophenyl)methoxy]carbonyl}-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |  | Formula: | C21 H30 F N3 O5 |  | SMILES: | C2(=O)C(CC(NC(C(CC(C)C)NC(OCc1cccc(F)c1)=O)=O)CO)CCN2 |  | InChi: | InChI=1S/C21H30FN3O5/c1-13(2)8-18(25-21(29)30-12-14-4-3-5-16(22)9-14)20(28)24-17(11-26)10-15-6-7-23-19(15)27/h3-5,9,13,15,17-18,26H,6-8,10-12H2,1-2H3,(H,23,27)(H,24,28)(H,25,29)/t15-,17-,18-/m0/s1 |  | Definition date: | 2021-01-13 |  | Last modified: | 2024-09-27 |  | Release date: | 2022-12-07 |  | Identifier: | N~2~-{[(3-fluorophenyl)methoxy]carbonyl}-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | 
 | 
|  | | YKD |  | Name: | (1S,2S)-2-((S)-2-((((2-(4,4-difluorocyclohexyl)propan-2-yl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl)propane-1-sulfonic acid |  | Formula: | C23 H37 F2 N3 O8 S |  | SMILES: | O=C1N=CCC1CC(NC(=O)C(CC(C)C)NC(=O)OC(C)(C)C1CCC(F)(F)CC1)C(O)S(=O)(=O)O |  | InChi: | InChI=1S/C23H37F2N3O8S/c1-13(2)11-16(28-21(32)36-22(3,4)15-5-8-23(24,25)9-6-15)19(30)27-17(20(31)37(33,34)35)12-14-7-10-26-18(14)29/h10,13-17,20,31H,5-9,11-12H2,1-4H3,(H,27,30)(H,28,32)(H,33,34,35)/t14-,16-,17-,20-/m0/s1 |  | Definition date: | 2021-03-11 |  | Last modified: | 2024-09-27 |  | Release date: | 2021-03-24 |  | Identifier: | (1S,2S)-2-{[N-({[2-(4,4-difluorocyclohexyl)propan-2-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propane-1-sulfonic acid | 
 | 
|  | | VQX |  | Name: | 8-azido-1-((1S,2S,3S,4S,5R,6S)-2,3,4-trihydroxy-5-(hydroxymethyl)-7-azabicyclo[4.1.0]heptan-7-yl)octan-1-one |  | Formula: | C15 H26 N4 O5 |  | SMILES: | OC[CH]1[CH](O)[CH](O)[CH](O)[CH]2[CH]1N2C(=O)CCCCCCCN=[N+]=[N-] |  | InChi: | InChI=1S/C15H26N4O5/c16-18-17-7-5-3-1-2-4-6-10(21)19-11-9(8-20)13(22)15(24)14(23)12(11)19/h9,11-15,20,22-24H,1-8H2/t9-,11-,12-,13-,14-,15-,19-/m0/s1 |  | Definition date: | 2023-08-07 |  | Last modified: | 2024-09-27 |  | Release date: | 2024-07-31 |  | Identifier: | 8-azido-1-[(1~{S},2~{R},3~{S},4~{S},5~{S})-2-(hydroxymethyl)-3,4,5-tris(oxidanyl)-7-azabicyclo[4.1.0]heptan-7-yl]octan-1-one | 
 | 
|  | | Y71 |  | Name: | (1S,2S)-2-((S)-2-(((((1S,2S,4S)-bicyclo[2.2.1]hept-5-en-2-yl)methoxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonic acid |  | Formula: | C22 H35 N3 O8 S |  | SMILES: | CC(C)C[CH](NC(=O)OC[CH]1C[CH]2C[CH]1C=C2)C(=O)N[CH](C[CH]3CCNC3=O)[CH](O)[S](O)(=O)=O |  | InChi: | InChI=1S/C22H35N3O8S/c1-12(2)7-17(25-22(29)33-11-16-9-13-3-4-14(16)8-13)20(27)24-18(21(28)34(30,31)32)10-15-5-6-23-19(15)26/h3-4,12-18,21,28H,5-11H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t13-,14+,15-,16+,17-,18-,21-/m0/s1 |  | Definition date: | 2021-02-08 |  | Last modified: | 2024-09-27 |  | Release date: | 2021-02-17 |  | Identifier: | (2~{S})-2-[[(2~{S})-2-[[(1~{S},2~{S},4~{S})-2-bicyclo[2.2.1]hept-5-enyl]methoxycarbonylamino]-4-methyl-pentanoyl]amino]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propane-1-sulfonic acid | 
 |